Ping An Healthcare and Technology Company Limited (HKG:1833)
10.85
+0.16 (1.50%)
Apr 29, 2026, 4:08 PM HKT
HKG:1833 Revenue
In the year 2025, Ping An Healthcare and Technology Company had annual revenue of 5.47B CNY with 13.73% growth. Ping An Healthcare and Technology Company had revenue of 2.97B in the half year ending December 31, 2025, with 20.99% growth.
Revenue
5.47B CNY
Revenue Growth
+13.73%
P/S Ratio
3.79
Revenue / Employee
3.28M CNY
Employees
1,668
Market Cap
23.07B HKD
Revenue Chart
* This company reports financials in CNY.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 5.47B | 660.09M | 13.73% |
| Dec 31, 2024 | 4.81B | 134.52M | 2.88% |
| Dec 31, 2023 | 4.67B | -1.53B | -24.68% |
| Dec 31, 2022 | 6.21B | -1.13B | -15.40% |
| Dec 31, 2021 | 7.33B | 468.23M | 6.82% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| XtalPi Holdings | 893.17M |
| QingSong Health | 1.40B |
| Xunfei Healthcare Technology | 1.02B |
| Yidu Tech | 812.73M |
| Medlive Technology | 714.60M |
| BrainAurora Medical Technology | 244.87M |
| HealthyWay | 1.74B |
| Zhejiang Taimei Medical Technology | 570.36M |
Ping An Healthcare and Technology Company News
- 9 months ago - Ping An Healthcare and Technology Company Earnings Call Transcript: H1 2025 - Transcripts
- 1 year ago - Ping An Healthcare and Technology Company Earnings Call Transcript: H2 2024 - Transcripts
- 1 year ago - Ping An Health and Medtronic Form Strategic Partnership at the China International Import Expo (CIIE) - PRNewsWire
- 3 years ago - Ping An Healthcare and Technology Company Earnings Call Transcript: H2 2022 - Transcripts